Preview

Современная ревматология

Расширенный поиск

Эффективность адалимумаба при увеитах у больных анкилозирующим спондилитом

https://doi.org/10.14412/1996-7012-2012-719

Полный текст:

Об авторе

Ш. Ф. Эрдес



Литература

1. <div><p>Зайцева Н.С., Кацнельсон Л.А. Увеиты. М.: Медицина, 1984; 318 с.</p><p>Smith J.R., Rosenbaum J.T. Management of uveitis. Arthr Rheum 2002; 46(2): 309—18.</p><p>Monnet D., Breban M., Hudry C. et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004; 111: 802—9.</p><p>Hooper C., Taylor S., Lightman S. Uveitis in Rheumatic Diseases. Cur Rheumatol Rev 2011; 7: 24—38.</p><p>Ревматология: национальное руководство. Под ред. Е.Л. Насонова, В.А.Насоновой. М.: ГЭОТАР-Медиа, 2008; 720 с.</p><p>Rosenbaum J.T., Smith J.R. Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 2002; 20(Suppl. 28): S143—5.</p><p>Hamideh F., Prete P.E. Ophthalmologic manifestations of rheumatic diseases. Semin Arthr Rheum 2001; 30: 217—41.</p><p>Chang J.H., McCluskey P.J., Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005; 50(4): 364—88.</p><p>Huerta-Sil G., Casasola-Vargas J.C., Londono J.D. et al. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis 2006; 65(5): 642—6.</p><p>DickA. D., Duncan L., Hale G. et al. Neutralizing TNF-alpha Activity Modulates T-cell Phenotype and Function in Experimental Autoimmune Uveoretinitis. J Autoimmunity 1998; 11: 255—64.</p><p>Dick A.D., Isaacs J.D. Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium. Br J Ophthalmol 1999; 83(11): 1230—4.</p><p>Lim L., Suhler E.B., Smith J.R. Biologic therapies of inflammatory eye disease. Clin Exp Ophthalmol 2006; 34(4): 365—74.</p><p>Santos Lacomba M., Marcos Marty’n C., Gallardo Galera J.M. et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001; 33: 251—5.</p><p>Braun J., Baraliakos X., Listing J. et al. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthr Rheum 2005; 52: 2447—51.</p><p>De Smet M.D. RESCU participants. Infliximab for uveitis: forty six week efficacy and safety results from the Remicade European Study for Chronic Uveitis (RESCU). Invest Ophthalmol Vis 2006; 47: E-Abstr 1525.</p><p>Guignard S., Gossec L., Salliot C. et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondyloarthropathy: a retrospective study. Ann Rheum Dis 2006; 65: 1631—4.</p><p>Saurenmann R.K., Levin A.V., Rose J.B. et al. Tumour necrosis factor a inhibitors in the treatment of childhood uveitis. Rheumatology Oxford 2006; 45: 982—9.</p><p>Tiliakos A.N., Tiliakos N.A. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary? J Rheumatol 2003; 30: 2727.</p><p>Hashkes P.J., Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheum 2003; 21: 645—6.</p><p>Reddy A.R., Backhouse O.C. Does etanercept induce uveitis? Br J Ophthalmol 2003; 87: 925.</p><p>Foster C.S., Tufail F., Waheed N.K. et al. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 2003; 121: 437—40.</p><p>Monnet D., Moachon L., Dougados M. et al. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat Clin Pract Rheum 2006; 2: 393—7.</p><p>Lim L.L., Fraunfelder F.W., Rosenbaum J.T. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthr Rheum 2007; 56: 3248—52.</p><p>Rudwaleit M., Rоdevand E., Holck P. et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study Ann Rheum Dis 2009; 68: 696—701.</p><p>Jabs D.A., Nussenblatt R.B., Rosenbaum J.T. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509—16.</p><p>Van der Horst-Bruinsma I., van Denderen J., Visman I. et al. Decreased Recurrence Rate of Anterior Uveitis in Ankylosing Spondylitis Treated with Adalimumab — An Interim Analysis. Abstr. 1933.</p><p>Roy S., Laitinen D., Reilly P. Impact of anti-tumor necrosis factor agents on newly diagnosed uveitis in patients with ankylosing spondylitis. Ann Rheum Dis 2011; 70(Suppl. 3): 432.</p></div><br />


Для цитирования:


Эрдес Ш.Ф. Эффективность адалимумаба при увеитах у больных анкилозирующим спондилитом. Современная ревматология. 2012;6(1):65-68. https://doi.org/10.14412/1996-7012-2012-719

For citation:


Erdes S.F. Efficacy of adalimumab in uveitis in patients with ankylosing spondylitis. Modern Rheumatology Journal. 2012;6(1):65-68. (In Russ.) https://doi.org/10.14412/1996-7012-2012-719

Просмотров: 559


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)